Over the last 7 days, the United States market has experienced a 2.4% drop, yet it has shown resilience with a 22% rise over the past year and anticipated earnings growth of 18% per annum in the coming years. In this environment, companies that exhibit strong growth potential coupled with high insider ownership may offer unique insights into their future prospects as insiders typically have a vested interest in their success.

Top 10 Growth Companies With High Insider Ownership In The United States

Name	Insider Ownership	Earnings Growth
Uxin (UXIN)	34.3%	74.1%
Upstart Holdings (UPST)	14.1%	58.5%
QT Imaging Holdings (QTI)	23.9%	104.2%
KVH Industries (KVHI)	16.3%	146.1%
Karman Holdings (KRMN)	15.6%	52.6%
IEH (IEHC)	37.3%	114.7%
Duos Technologies Group (DUOT)	11.2%	158.4%
Corcept Therapeutics (CORT)	10.9%	48.9%
Astera Labs (ALAB)	10.1%	29.3%
AppLovin (APP)	27.5%	21.7%

Let's review some notable picks from our screened stocks.

Hesai Group (HSAI)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Hesai Group develops, manufactures, and sells three-dimensional LiDAR solutions across Mainland China, Europe, North America, and internationally with a market cap of approximately $2.74 billion.

Operations: Hesai Group's revenue primarily comes from the development, manufacturing, and sale of three-dimensional LiDAR solutions across various regions including Mainland China, Europe, and North America.

Insider Ownership: 17.5%

Earnings Growth Forecast: 27.4% p.a.

Hesai Group is experiencing robust growth, with revenue forecasted to increase at 26.5% annually, outpacing the US market. The company became profitable this year and expects earnings to grow significantly at 27.4% per year. Despite past shareholder dilution, Hesai trades below estimated fair value and analysts agree on a potential price rise of 67.6%. Recent strategic partnerships with top-tier automakers like Mercedes-Benz highlight its strong market position in lidar technology for autonomous vehicles.

Circle Internet Group (CRCL)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Circle Internet Group, Inc. operates as a platform, network, and market infrastructure for stablecoin and blockchain applications with a market cap of $19.62 billion.

Operations: The company generates revenue from its data processing segment, which amounts to $2.86 billion.

Insider Ownership: 11.6%

Earnings Growth Forecast: 49% p.a.

Circle Internet Group is poised for substantial growth, with revenue expected to rise by 22.1% annually, surpassing the US market average. Despite recent insider selling and high share price volatility, the company is forecasted to become profitable within three years. Recent product launches like Circle Agent Stack and strategic collaborations aim to enhance its position in digital payments and stablecoin infrastructure. However, legal challenges persist due to a significant cryptocurrency exploit involving its USDC stablecoin.

Karman Holdings (KRMN)

Simply Wall St Growth Rating: ★★★★★★

Overview: Karman Holdings Inc., with a market cap of $6.08 billion, operates in the United States through its subsidiary by designing, testing, manufacturing, and selling mission-critical systems.

Operations: The company's revenue is primarily generated from the Space and Defense Industry, amounting to $522.59 million.

Insider Ownership: 15.6%

Earnings Growth Forecast: 52.6% p.a.

Karman Holdings is positioned for growth with revenue projected to increase by 27.7% annually, outpacing the US market. Despite concerns over interest coverage, earnings are expected to grow significantly at 52.6% per year. Recent developments include a follow-on equity offering of US$854 million and strategic leadership changes aimed at enhancing digital and AI capabilities. The company also secured contingent demand commitments worth over $1 billion from key space and defense customers, indicating robust future demand for its solutions.

Taking Advantage

• Discover the full array of 173 Fast Growing US Companies With High Insider Ownership right here.
• Contemplating Other Strategies? AI is about to change healthcare. These 133 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.